New option listings for September 3rd include Oruka Therapeutics Inc (ORKA). Option delistings effective September 3rd include ARCA Biopharma (ABIO).
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABIO:
- Oruka announces closing of merger with ARCA Biopharma
- ARCA Biopharma trading halted, news pending
- ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
- ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
- ARCA Biopharma updates on special dividend related to Oruka merger